Regulations.gov document
Determination of Regulatory Review Period for Purposes of Patent Extension; AGILI–C
Notice · FDA-2023-E-2611 · posted Nov 19, 2024
Key facts
| Document ID | FDA-2023-E-2611-0006 |
|---|---|
| Title | Determination of Regulatory Review Period for Purposes of Patent Extension; AGILI–C |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2023-E-2611 |
| Posted | Nov 19, 2024 |
| Federal Register citation | 89 FR 91402 |
| FR document number | 2024-26910 |
| Comment period opens | Nov 19, 2024 |
| Comments due | Jan 22, 2025 |
| Effective date | Nov 19, 2024 |
At a glance
- 1–9 Pages
- No Open for comment
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: